首页> 美国卫生研究院文献>Yonsei Medical Journal >Two Cases of Acute Leukopenia Induced by Colchicine with Concurrent Immunosuppressants Use in Behçets Disease
【2h】

Two Cases of Acute Leukopenia Induced by Colchicine with Concurrent Immunosuppressants Use in Behçets Disease

机译:秋水仙碱联合并用免疫抑制剂治疗白塞病致急性白细胞减少症两例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colchicine-induced leukopenia usually occurrs in intentional or accidental overdoses or inappropriate use in combination with intravenous and oral colchine; however, there have been several reports of hematologic toxicity in short-term and small-dose colchicine medication courses. We present two cases of leukopenia induced by colchicine use concurrent with immunosuppressants in Behçet's disease. We postulate that the mechanism of colchicine-induced leukopenia might be the destruction of circulating leukocytes and an inhibition of leukocyte production by the immediate and direct toxic effect of colchicine on idiosyncrasies unique to each patient. The concurrently administered immunosuppressant might decrease the threshold for hematologic toxicity of colchicine in the leukocytes and their precursor cells.
机译:秋水仙碱诱导的白细胞减少症通常发生于有意或无意的过量服用或与静脉和口服秋水仙碱联合使用不当;但是,短期和小剂量秋水仙碱药物治疗过程中有血液毒性的报道。我们提出了两例由秋水仙碱引起的白细胞减少症并伴有白塞病患者的免疫抑制剂。我们推测秋水仙碱诱导的白细胞减少症的机制可能是循环血白细胞的破坏和秋水仙碱对每位患者特有的直接和直接毒性作用的抑制白细胞产生。同时使用免疫抑制剂可能会降低秋水仙碱对白细胞及其前体细胞血液学毒性的阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号